FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
6/20/2025 5:25:30 PM | Chg. +0.310 | Volume | Bid9:57:30 PM | Ask9:57:30 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.940EUR | +0.74% | 12 Turnover: 503.760 |
41.550Bid Size: 250 | 41.900Ask Size: 250 | 23.66 bill.EUR | 2.38% | 50.01 |
GlobeNewswire
3/18
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Acc...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil